The Vaxcyte company source record lists 492 employees. The visible Vaxcyte management graph includes:
Derek Chowning
Director of Facilities @Vaxcyte
5
2
General
(58)
Dan Griffin, Ph.d.
Executive Director, Global Drug Substance Commercialization Lead at Vaxcyte
0
0
IT
(14)
Alexandra D.
Data Systems Specialist - Cmc IT
3
0
Healthcare
(4)
Guy Hagen
Director, Clinical Quality Assurance
4
3
Operations
(3)
Nicholas Rummel
Senior Manager, Pilot Plant Operations
6
5
Legal
(1)
Robert Bitman
Corporate Counsel at Vaxcyte
2
0
HR
(1)
Jessica Whiting, Acc
Director, Talent Development
0
0
Marketing
(1)
Amy Walsh, Cpcc
Communications - Professional Coach - Dei Practitioner
0
0
Finance
(1)
Maribel Sandoval
Financial Professional
0
0
Vaxcyte people graph sample
-
April Ruiz
HR Business Partner
San Francisco, California, United States3 email signals: 1 email signal on vaxcyte.com, 2 non-official email signals1 phone signal available
-
Lars Bonefeld
Wellesley, Massachusetts, United States3 email signals: 1 email signal on vaxcyte.com, 2 non-official email signals -
Peter Fawzi
Global Finance & Accounting Operations
San Francisco Bay Area, United States5 email signals across 5 non-official domains -
Heath Lukatch
San Francisco, California, United States2 email signals across 2 non-official domains
How AeroLeads builds company intelligence
Use source-backed company records
AeroLeads combines company source fields, workforce samples, email-pattern aggregates, and related-company records when those signals are available.
Show only available evidence
Blank source fields are omitted. Contact channels are summarized as signals, with raw email addresses and phone numbers masked on public pages.
Compare useful company context
Related company, market, workforce, technology, and management signals help turn a static company listing into a company intelligence page.
Contact research
AeroLeads intelligence
Review reachable contact coverage for Vaxcyte
AeroLeads maps 4 visible contact signals for Vaxcyte. Coverage is multi-channel contact coverage.